Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profiling of non-small cell lung cancer.
Forsythe ML, Alwithenani A, Bethune D, Castonguay M, Drucker A, Flowerdew G, French D, Fris J, Greer W, Henteleff H, MacNeil M, Marignani P, Morzycki W, Plourde M, Snow S, Xu Z. Forsythe ML, et al. Among authors: morzycki w. PLoS One. 2020 Aug 5;15(8):e0236580. doi: 10.1371/journal.pone.0236580. eCollection 2020. PLoS One. 2020. PMID: 32756609 Free PMC article.
Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR.
Alwithenani A, Bethune D, Castonguay M, Drucker A, Flowerdew G, Forsythe M, French D, Fris J, Greer W, Henteleff H, MacNeil M, Marignani P, Morzycki W, Plourde M, Snow S, Marcato P, Xu Z. Alwithenani A, et al. Among authors: morzycki w. PLoS One. 2021 May 6;16(5):e0251080. doi: 10.1371/journal.pone.0251080. eCollection 2021. PLoS One. 2021. PMID: 33956842 Free PMC article.
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.
Bebb DG, Agulnik J, Albadine R, Banerji S, Bigras G, Butts C, Couture C, Cutz JC, Desmeules P, Ionescu DN, Leighl NB, Melosky B, Morzycki W, Rashid-Kolvear F, Lab C, Sekhon HS, Smith AC, Stockley TL, Torlakovic E, Xu Z, Tsao MS. Bebb DG, et al. Among authors: morzycki w. Curr Oncol. 2019 Aug;26(4):e551-e557. doi: 10.3747/co.26.5137. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548824 Free PMC article.
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Melosky B, Agulnik J, Albadine R, Banerji S, Bebb DG, Bethune D, Blais N, Butts C, Cheema P, Cheung P, Cohen V, Deschenes J, Ionescu DN, Juergens R, Kamel-Reid S, Laurie SA, Liu G, Morzycki W, Tsao MS, Xu Z, Hirsh V. Melosky B, et al. Among authors: morzycki w. Curr Oncol. 2016 Jun;23(3):196-200. doi: 10.3747/co.23.3120. Epub 2016 Jun 9. Curr Oncol. 2016. PMID: 27330348 Free PMC article.
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Melosky B, Cheema P, Agulnik J, Albadine R, Bebb DG, Blais N, Burkes R, Butts C, Card PB, Chan AMY, Hirsh V, Ionescu DN, Juergens R, Morzycki W, Poonja Z, Sangha R, Tehfe M, Tsao MS, Vincent M, Xu Z, Liu G. Melosky B, et al. Among authors: morzycki w. Curr Oncol. 2018 Oct;25(5):317-328. doi: 10.3747/co.25.4379. Epub 2018 Oct 31. Curr Oncol. 2018. PMID: 30464681 Free PMC article. Review.
Adjuvant chemotherapy uptake in non-small cell lung cancer.
Younis T, Al-Fayea T, Virik K, Morzycki W, Saint-Jacques N. Younis T, et al. Among authors: morzycki w. J Thorac Oncol. 2008 Nov;3(11):1272-8. doi: 10.1097/JTO.0b013e318189f562. J Thorac Oncol. 2008. PMID: 18978562 Free article.
Waiting times in early-stage non-small cell lung cancer (NSCLC).
Saint-Jacques N, Rayson D, Al-Fayea T, Virik K, Morzycki W, Younis T. Saint-Jacques N, et al. Among authors: morzycki w. J Thorac Oncol. 2008 Aug;3(8):865-70. doi: 10.1097/JTO.0b013e318180210c. J Thorac Oncol. 2008. PMID: 18670304 Free article.
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement.
Ellis PM, Morzycki W, Melosky B, Butts C, Hirsh V, Krasnoshtein F, Murray N, Shepherd FA, Soulieres D, Tsao MS, Goss G. Ellis PM, et al. Among authors: morzycki w. Curr Oncol. 2009 Jan;16(1):27-48. doi: 10.3747/co.v16i1.393. Curr Oncol. 2009. PMID: 19229369 Free PMC article.
Brief report: a phase II study of sunitinib in malignant pleural mesothelioma. the NCIC Clinical Trials Group.
Laurie SA, Gupta A, Chu Q, Lee CW, Morzycki W, Feld R, Foo AH, Seely J, Goffin JR, Laberge F, Murray N, Rao S, Nicholas G, Laskin J, Reiman T, Sauciuc D, Seymour L. Laurie SA, et al. Among authors: morzycki w. J Thorac Oncol. 2011 Nov;6(11):1950-4. doi: 10.1097/JTO.0b013e3182333df5. J Thorac Oncol. 2011. PMID: 22005473 Free article. Clinical Trial.
17 results